Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT00736879

Public ClinicalTrials.gov record NCT00736879. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 1:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical research study is to learn if BMS-512148 (Dapagliflozin) can help reduce the blood sugar levels in subjects with Type 2 Diabetes who are not well controlled on diet and exercise alone. The safety of this treatment will also be studied

Study identification

NCT ID
NCT00736879
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
497 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 77 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 21, 2008
Primary completion
Dec 28, 2009
Completion
Dec 28, 2009
Last update posted
Apr 19, 2017

2008 – 2009

United States locations

U.S. sites
26
U.S. states
16
U.S. cities
26
Facility City State ZIP Site status
Dedicated Clinical Research Litchfield Park Arizona 85340
43rd Medical Associates, P.C. Phoenix Arizona 85051
Clinical Research Advantage, Inc. Tempe Arizona 85282
Valley Research Fresno California 93720
Marina Raikhel, Md, Faafp Lomita California 90717
Richard S. Cherlin, Md Los Gatos California 95032
Orange County Research Center Tustin California 92780
Family Physicians Of Greeley Greeley Colorado 80634
Coastal Connecticut Research, Llc New London Connecticut 06320
Central Florida Clinical Trials, Inc. Altamonte Springs Florida 32701
Westside Center For Clinical Research Jacksonville Florida 32205
Panhandle Family Care Associates Marianna Florida 32446
Endocrine Research Solutions, Inc. Roswell Georgia 30076
Belzoni Clinical Research Belzoni Mississippi 39038
R-Research Hamilton New Jersey 08690
Internist Associates Of Central New York Syracuse New York 13210
Southgate Medical Group West Seneca New York 14224
Down East Medical Associates, Pa Morehead City North Carolina 28557
James J. Brown, Md Akron Ohio 44319
Integris Family Care South Oklahoma City Oklahoma 73170
Southeastern Research Associates, Inc. Taylors South Carolina 29687
Abbott Clinical Research Group, Inc San Antonio Texas 78224
Avastra Clinical Trials Midvale Utah 84047
Optimum Clinical Research, Inc. Salt Lake City Utah 84102
Capital Clinical Research Center Olympia Washington 98502
Stephen G. Danley, Do Spokane Washington 99216

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00736879, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 19, 2017 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00736879 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →